- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x E2Q: 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide(Non-covalent)
- 46 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.2: 8 residues within 4Å:- Chain A: F.537, F.596, I.820
- Chain B: I.621
- Ligands: PC1.3, PC1.5, PC1.8, PC1.37
Ligand excluded by PLIPPC1.3: 8 residues within 4Å:- Chain A: L.540, Y.545, W.548, I.551, Y.555
- Chain B: F.628
- Ligands: PC1.2, PC1.37
Ligand excluded by PLIPPC1.4: 4 residues within 4Å:- Chain A: V.536, G.823, G.824
- Ligands: PC1.5
Ligand excluded by PLIPPC1.5: 7 residues within 4Å:- Chain A: L.827, I.834, E.835, Y.838
- Ligands: PC1.2, PC1.4, PC1.8
Ligand excluded by PLIPPC1.6: 7 residues within 4Å:- Chain A: I.822, G.823
- Chain B: F.567
- Chain C: V.15, A.18, M.153
- Ligands: PC1.18
Ligand excluded by PLIPPC1.7: 6 residues within 4Å:- Chain A: R.616
- Chain E: F.595, E.834
- Ligands: PC1.29, PC1.32, PC1.34
Ligand excluded by PLIPPC1.8: 6 residues within 4Å:- Chain A: Y.555, F.596
- Chain B: Y.570
- Ligands: PC1.2, PC1.5, PC1.38
Ligand excluded by PLIPPC1.10: 10 residues within 4Å:- Chain B: L.539, Y.544, W.547, M.548, Y.554, L.602, F.605, M.606
- Ligands: PC1.11, PC1.16
Ligand excluded by PLIPPC1.11: 5 residues within 4Å:- Chain B: Y.554, I.555
- Ligands: PC1.10, PC1.16, PC1.42
Ligand excluded by PLIPPC1.12: 5 residues within 4Å:- Chain B: V.535, G.823
- Chain D: A.116
- Ligands: PC1.13, PC1.16
Ligand excluded by PLIPPC1.13: 4 residues within 4Å:- Chain B: Y.818, G.825
- Chain D: A.166
- Ligands: PC1.12
Ligand excluded by PLIPPC1.14: 4 residues within 4Å:- Chain B: I.833, E.834, Y.837
- Ligands: PC1.42
Ligand excluded by PLIPPC1.15: 6 residues within 4Å:- Chain B: F.835, C.836
- Chain D: N.155, I.162, L.163, A.166
Ligand excluded by PLIPPC1.16: 12 residues within 4Å:- Chain B: F.536, Y.544, F.595, L.598, W.599, L.602, I.819
- Chain G: F.629
- Ligands: PC1.10, PC1.11, PC1.12, PC1.42
Ligand excluded by PLIPPC1.17: 10 residues within 4Å:- Chain B: V.559, F.562, R.566, I.594
- Chain C: V.69, P.70, S.73, G.76, L.77
- Ligands: PC1.20
Ligand excluded by PLIPPC1.18: 7 residues within 4Å:- Chain A: F.836
- Chain C: I.21, F.22, I.25, W.26, I.29
- Ligands: PC1.6
Ligand excluded by PLIPPC1.19: 2 residues within 4Å:- Chain C: L.83, W.88
Ligand excluded by PLIPPC1.20: 2 residues within 4Å:- Chain C: W.88
- Ligands: PC1.17
Ligand excluded by PLIPPC1.22: 5 residues within 4Å:- Chain D: L.136, L.139, C.143, N.155, I.156
Ligand excluded by PLIPPC1.23: 6 residues within 4Å:- Chain D: S.199, Y.200, Y.205
- Chain G: Y.545
- Ligands: PC1.44, PC1.45
Ligand excluded by PLIPPC1.24: 5 residues within 4Å:- Chain D: I.212, V.216, V.219, N.223
- Ligands: PC1.35
Ligand excluded by PLIPPC1.25: 4 residues within 4Å:- Chain D: Y.45, W.202, Y.205, F.206
Ligand excluded by PLIPPC1.26: 4 residues within 4Å:- Chain D: E.15, V.18, Q.19, L.213
Ligand excluded by PLIPPC1.28: 10 residues within 4Å:- Chain E: L.539, Y.544, W.547, M.548, Y.554, L.602, F.605, M.606
- Ligands: PC1.29, PC1.34
Ligand excluded by PLIPPC1.29: 5 residues within 4Å:- Chain E: Y.554, I.555
- Ligands: PC1.7, PC1.28, PC1.34
Ligand excluded by PLIPPC1.30: 5 residues within 4Å:- Chain E: V.535, G.823
- Chain F: A.116
- Ligands: PC1.31, PC1.34
Ligand excluded by PLIPPC1.31: 3 residues within 4Å:- Chain E: Y.818, G.825
- Ligands: PC1.30
Ligand excluded by PLIPPC1.32: 4 residues within 4Å:- Chain E: I.833, E.834, Y.837
- Ligands: PC1.7
Ligand excluded by PLIPPC1.33: 5 residues within 4Å:- Chain E: F.835, C.836
- Chain F: I.162, L.163, A.166
Ligand excluded by PLIPPC1.34: 12 residues within 4Å:- Chain A: F.629
- Chain E: F.536, Y.544, F.595, L.598, W.599, L.602, I.819
- Ligands: PC1.7, PC1.28, PC1.29, PC1.30
Ligand excluded by PLIPPC1.35: 6 residues within 4Å:- Chain E: Y.570
- Chain G: Y.555, F.596
- Ligands: PC1.24, PC1.44, PC1.47
Ligand excluded by PLIPPC1.36: 10 residues within 4Å:- Chain E: V.559, F.562, R.566, I.594
- Chain H: V.69, P.70, S.73, G.76, L.77
- Ligands: PC1.51
Ligand excluded by PLIPPC1.37: 6 residues within 4Å:- Chain A: Y.545
- Chain F: S.199, Y.200, Y.205
- Ligands: PC1.2, PC1.3
Ligand excluded by PLIPPC1.38: 4 residues within 4Å:- Chain F: I.212, V.219, N.223
- Ligands: PC1.8
Ligand excluded by PLIPPC1.39: 3 residues within 4Å:- Chain F: Y.45, Y.205, F.206
Ligand excluded by PLIPPC1.40: 5 residues within 4Å:- Chain F: E.15, V.18, Q.19, I.212, L.213
Ligand excluded by PLIPPC1.41: 4 residues within 4Å:- Chain F: L.136, L.139, N.155, I.156
Ligand excluded by PLIPPC1.42: 6 residues within 4Å:- Chain B: F.595, E.834
- Chain G: R.616
- Ligands: PC1.11, PC1.14, PC1.16
Ligand excluded by PLIPPC1.44: 7 residues within 4Å:- Chain G: F.537, F.596, I.820
- Ligands: PC1.23, PC1.35, PC1.45, PC1.47
Ligand excluded by PLIPPC1.45: 8 residues within 4Å:- Chain E: F.628
- Chain G: L.540, Y.545, W.548, I.551, Y.555
- Ligands: PC1.23, PC1.44
Ligand excluded by PLIPPC1.46: 4 residues within 4Å:- Chain G: V.536, G.823, G.824
- Ligands: PC1.47
Ligand excluded by PLIPPC1.47: 7 residues within 4Å:- Chain G: L.827, I.834, E.835, Y.838
- Ligands: PC1.35, PC1.44, PC1.46
Ligand excluded by PLIPPC1.48: 7 residues within 4Å:- Chain E: F.567
- Chain G: I.822, G.823
- Chain H: V.15, A.18, M.153
- Ligands: PC1.50
Ligand excluded by PLIPPC1.49: 2 residues within 4Å:- Chain H: L.83, W.88
Ligand excluded by PLIPPC1.50: 7 residues within 4Å:- Chain G: F.836
- Chain H: A.18, I.21, F.22, I.25, W.26
- Ligands: PC1.48
Ligand excluded by PLIPPC1.51: 2 residues within 4Å:- Chain H: W.88
- Ligands: PC1.36
Ligand excluded by PLIP- 2 x CLR: CHOLESTEROL(Non-covalent)
CLR.21: 4 residues within 4Å:- Chain C: Y.100, Y.130, K.133, K.138
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:Y.100, C:Y.100, C:Y.130, C:K.133, C:K.138
CLR.52: 4 residues within 4Å:- Chain H: Y.100, Y.130, K.133, K.138
5 PLIP interactions:5 interactions with chain H- Hydrophobic interactions: H:Y.100, H:Y.100, H:Y.130, H:K.133, H:K.138
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Gating and modulation of a hetero-octameric AMPA glutamate receptor. Nature (2021)
- Release Date
- 2021-06-09
- Peptides
- Glutamate receptor 1: AG
Glutamate receptor 2: BE
Protein cornichon homolog 2: CH
Voltage-dependent calcium channel gamma-8 subunit: DF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
CB
BE
DC
GH
ED
IF
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x E2Q: 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide(Non-covalent)
- 46 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Gating and modulation of a hetero-octameric AMPA glutamate receptor. Nature (2021)
- Release Date
- 2021-06-09
- Peptides
- Glutamate receptor 1: AG
Glutamate receptor 2: BE
Protein cornichon homolog 2: CH
Voltage-dependent calcium channel gamma-8 subunit: DF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
CB
BE
DC
GH
ED
IF
J - Membrane
-
We predict this structure to be a membrane protein.